<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FE0E616-6A75-4DCC-BA07-3ADF018A9669"><gtr:id>9FE0E616-6A75-4DCC-BA07-3ADF018A9669</gtr:id><gtr:name>National Cancer Research Institute</gtr:name><gtr:address><gtr:line1>National Cancer Research Institute</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/92F81743-12CA-4C06-9CDF-5AB4B09B6F38"><gtr:id>92F81743-12CA-4C06-9CDF-5AB4B09B6F38</gtr:id><gtr:name>Sir Charles Gairdner Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FE0E616-6A75-4DCC-BA07-3ADF018A9669"><gtr:id>9FE0E616-6A75-4DCC-BA07-3ADF018A9669</gtr:id><gtr:name>National Cancer Research Institute</gtr:name><gtr:address><gtr:line1>National Cancer Research Institute</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/92F81743-12CA-4C06-9CDF-5AB4B09B6F38"><gtr:id>92F81743-12CA-4C06-9CDF-5AB4B09B6F38</gtr:id><gtr:name>Sir Charles Gairdner Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B04AE213-F76F-4162-B08C-F97885212230"><gtr:id>B04AE213-F76F-4162-B08C-F97885212230</gtr:id><gtr:firstName>Najib</gtr:firstName><gtr:surname>Rahman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600475"><gtr:id>A3188719-3FD8-4DBC-9F76-DB9151D6DE49</gtr:id><gtr:title>The Therapeutic Interventions in Malignant Pleural Effusions Trial (the TIME trial)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600475</gtr:grantReference><gtr:abstractText>This application is for me to perform a clinical trial to improve care for patients with abnormal chest fluid collections between the lung and the chest wall, and to provide me with training in clinical trials. Over 250,000 patients in the UK and US each year develop fluid collections between the lung and the chest wall, which causes disabling breathlessness. One of the commonest causes of such fluid is cancer cells in the membranes between the lung and the chest wall that alter fluid regulation. To control this fluid, an irritant drug is applied to the chest cavity where the fluid collects to cause inflammation, adhering the lung to the chest wall. This treatment is very painful and this pain may be reduced by using non-steroidal painkillers rather than opiate painkillers (standard care), and by using small chest tubes for drug delivery. However, such non-steroidal analgesics may, theoretically, impair the efficiency of this treatment. This trial will establish if non-steroidal analgesics and small bore chest tubes can decrease pain, and whether non-steroidal analgesics do actually change treatment effectiveness. Whatever its result, this study will produce new information about treating these patients and will provide me with a thorough training in clinical trial method.</gtr:abstractText><gtr:technicalSummary>This Training Fellowship is to perform a trial in malignant pleural effusion and to provide me with the research training in clinical trials. 
The proposed study is a 2x2 factorial trial to assess whether non-steroidal (ibuprofen) analgesia and the use of small bore chest tubes reduce pain during pleurodesis for malignant effusion, compared to standard care. The trial will also define whether non-steroidal use decreases pleurodesis efficacy.
Based on our preliminary data, we hope to demonstrate improved pain control over 72 hours post pleurodesis using validated visual analogue scales (primary endpoint). Secondary endpoints are time to relapse of pleural effusion (survival analysis) and the presence of chronic chest pain at 3 months. 
Delivery of this trial will be in collaboration with the MRC Clinical Trials Unit and will use the recruitment centres assembled by previous Oxford pleural trials (in pleural infection). In parallel with the delivery of this trial, I will gain statistical training and trials experience by involvement in the delivery processes of other Oxford and MRC CTU multi-centre trials, providing the foundation for a career in respiratory clinical research.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>214705</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Academic Respiratory Unit (ARU)</gtr:department><gtr:description>UK Clinical Research Network Oxford Respiratory Trials Unit Pleural Disease Research Network</gtr:description><gtr:id>94AADC88-6B52-4C19-B34F-672DA413451B</gtr:id><gtr:impact>The Maligant Pleural Disease Network will enable efficient recruitment to the TIME1 study, which is now on course to completion before the target date. Within each centre, the nomination of a single respiratory physician as Principle Investigator for TIME1 has enabled streamlining of treatment pathways for malignant pleural effusion which is a common and disabling disease. There are currently 12 UK centres in this colloboration (Nottingham, Taunton, Medway, Central Manchester, North Manchester, Hastings, Portsmouth, Basildon, Blackpool, Preston, Wolvehampton), and 2 international centres (Vancouver, California) actively recruiting to the TIME1 trial, with an additional 5 UK centres in the process of set up. For UK centres, the TIME1 study has been included in the portfolios of both the UK Clinical Research Network and the National Cancer Research Network. Through these established mechanisms, centres have been able to achieve resource to help delivery of the study. This resource will be used in future multi-centre interventional and observational studies of pleural disease thereby creating a network of recruting centres with a proven track record in trial delivery and recruitment. 

This has now been extended to include other disease areas such as pneumothorax.</gtr:impact><gtr:outcomeId>8331C114B79-1</gtr:outcomeId><gtr:partnerContribution>Recruitment to multicentre malignant pleural disease trials. This collaboration is now being used for a number of multi-centre clinical trials in pleural disease including an assessment of the use of indwelling pleural catheters, and a comparison of talc slurry pleurodesis compared to talc poudrage funded by the HTA process. 

This has now been extended to include 10 centres with an interest in pneumothorax for the RAMMP trial.</gtr:partnerContribution><gtr:piContribution>Recruitment of interested centres and clinicians to the collaboration, training of individual centres in effective trial delivery. This was started with the University of Bristol (Dr N Maskell) but now includes multiple (15) UK NHS sites.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vanderbilt University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vanderbilt Medical Center</gtr:department><gtr:description>INTERNATIONAL RESEARCH PARTNERSHIP</gtr:description><gtr:id>9E3875B6-21D0-488F-B7CD-CD82F1BA627F</gtr:id><gtr:impact>Recruitment to current study, discussion around potential recruitment to future studies</gtr:impact><gtr:outcomeId>56e07ad9a514d5.34869596-1</gtr:outcomeId><gtr:partnerContribution>Recruitment to trials, input on to trial committees</gtr:partnerContribution><gtr:piContribution>Through the MRC grant to conduct the PILOT study, we have established an international recruitment base for pleural trials which includes centres in Australia, the USA and South Africa. These are now actively recruiting patients to the trial and will be used in future for large scale pleural trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>Oxford Respiratory Trials Unit and MRC Clinical Trials Unit</gtr:description><gtr:id>8AA8396E-2EF8-4FB6-8691-09EE992BD69C</gtr:id><gtr:impact>Completion and current analysis of a multicentre trial assessing novel therapies in pleural infection (MIST2). Ongoing recruitment to a randomised multicentre trial assessing optimal analgesic strategy and tube size for the treatment of malignant pleural effusion (TIME1) Ongoing recruitment to a randomised multicentre trial assessing the use of indwelling pleural catheters in the treatment of malignant pleural effusion (TIME2) Design and set up phase of a multicentre randomised trial assessing intrapleural fibrinolytic therapies for the treatment of malignant pleural effusion (TIME3)</gtr:impact><gtr:outcomeId>210246D09A1-1</gtr:outcomeId><gtr:partnerContribution>Shared management of trial design / conduct / analysis between Oxford Respiratory Trials Unit and MRC Clinical Trials Unit for multicentre trials in pleural disease and sleep apnoea</gtr:partnerContribution><gtr:piContribution>Collaboration in trial design, conduct and analysis of multicentre randomised studies in pleural disease</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Clinical Research Network</gtr:description><gtr:id>5C8391A0-027E-462B-96F4-A0F15C7DF5A9</gtr:id><gtr:impact>The Oxford Respiratory Trials Unit is the only respiratory specific trials unit in the UK, and inclusion of multicentre pleural disease trials on its portfolio (TIME1 / TIME2 / TIME3) has permitted use of UKCRN resources to recruit to trials and smooth trial delivery This collaboration has enabled smooth and efficient trial delivery in centres, permitting multicentre recruitment and on target trial delivery</gtr:impact><gtr:outcomeId>F733E7286E8-1</gtr:outcomeId><gtr:partnerContribution>Inclusion of multicentre pleural disease in portfolio of UKCRN trials permits recruitment of trial delivery nursing staff in local centres.</gtr:partnerContribution><gtr:piContribution>Application for inclusion of the TIME trials in the UKCRN portfolio. Access to UKCRN resource for centres delivering the trial</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Cancer Research Institute (NCRI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Cancer Research Network (NCRN)</gtr:department><gtr:description>National Cancer Research Network</gtr:description><gtr:id>C3642B76-5783-4E29-9237-E78B7A091690</gtr:id><gtr:impact>Inclusion of the TIME1 trial on the NCRN portfolio of studies has allowed centres to use NCRN nursing resource to aid recruitment and trial delivery locally</gtr:impact><gtr:outcomeId>1D7DF566A06-1</gtr:outcomeId><gtr:partnerContribution>Support of multicentre recruitment to the TIME1 trial using NCRN registered nursing practitioners in all participating centres</gtr:partnerContribution><gtr:piContribution>Support of multicentre recruitment to the TIME1 trial using NCRN registered nursing practitioners in all participating centres</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sir Charles Gairdner Hospital</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Lung Institute of Western Australia (LIWA)</gtr:department><gtr:description>Western Australia</gtr:description><gtr:id>D8231E5A-390F-416F-9B3B-96CE3BC4B410</gtr:id><gtr:impact>The genetic profiling of malignant pleural disease, and specifically malignant mesothelioma, is a collaborative project formed between our unit and our collaborators. Our collaborators have an interest in the biology and physiological mechanisms behind malignant pleural disease and pleurodesis. The TIME1 trial has permitted the set up of a biobank of pleural fluid samples with associated clinical information, allowing meaningful translational work to be conducted.</gtr:impact><gtr:outcomeId>AD2A595DA36-1</gtr:outcomeId><gtr:partnerContribution>Analysis of genetic markers of mesothelioma; investigation of the biology of pleurodesis permitting translation of novel molecules to the clinical setting</gtr:partnerContribution><gtr:piContribution>Contribution of clinical samples and clinical data</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Western Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>INTERNATIONAL RESEARCH PARTNERSHIP</gtr:description><gtr:id>6AB2C5A0-F0FE-4E7B-BE6B-E4C6D535644C</gtr:id><gtr:impact>Recruitment to current study, discussion around potential recruitment to future studies</gtr:impact><gtr:outcomeId>56e07ad9a514d5.34869596-3</gtr:outcomeId><gtr:partnerContribution>Recruitment to trials, input on to trial committees</gtr:partnerContribution><gtr:piContribution>Through the MRC grant to conduct the PILOT study, we have established an international recruitment base for pleural trials which includes centres in Australia, the USA and South Africa. These are now actively recruiting patients to the trial and will be used in future for large scale pleural trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical Sciences Division</gtr:department><gtr:description>Microbiology collaboration</gtr:description><gtr:id>49D3108A-BEDE-4F7B-8E8C-E55D7C1B3177</gtr:id><gtr:impact>Nil thus far</gtr:impact><gtr:outcomeId>orKaTdjUXQW-1</gtr:outcomeId><gtr:partnerContribution>Advice has been received from collaborators in microbiology on optimal sample collection and storage for this future collaboration</gtr:partnerContribution><gtr:piContribution>Prospectively collected samples will be used to assess the microbiological profile of pleural infection, and tested using novel DNA based techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>CRUK/MRC Oxford Institute for Radiation Oncology</gtr:department><gtr:description>Oxford Radiology Collaboration</gtr:description><gtr:id>1429687C-DD6C-40C7-93A6-8DE605D376E6</gtr:id><gtr:impact>The Oxford RTU works closely with the Department of Radiology in Oxford in the design and conduct of trials in pleural disease. This has enabled a large cohort of patients with well defined clinical pleural syndromes to be assessed with varying radiological techniques. This has led to new insights in to radiological assessment of pleural diseases (work ongoing).</gtr:impact><gtr:outcomeId>F96B4581BC2-1</gtr:outcomeId><gtr:partnerContribution>Essential support in trial design and delivery of pleural disease trials, assessing novel radiological techniques and imaging (thoracic ultrasound, CT) for malignant pleural disease</gtr:partnerContribution><gtr:piContribution>Intellectual input, access to well defined clinical patient cohorts</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Stellenbosch</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>INTERNATIONAL RESEARCH PARTNERSHIP</gtr:description><gtr:id>4E827662-A731-437D-92D9-07639D70441A</gtr:id><gtr:impact>Recruitment to current study, discussion around potential recruitment to future studies</gtr:impact><gtr:outcomeId>56e07ad9a514d5.34869596-2</gtr:outcomeId><gtr:partnerContribution>Recruitment to trials, input on to trial committees</gtr:partnerContribution><gtr:piContribution>Through the MRC grant to conduct the PILOT study, we have established an international recruitment base for pleural trials which includes centres in Australia, the USA and South Africa. These are now actively recruiting patients to the trial and will be used in future for large scale pleural trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>&quot;Breath Easy&quot; Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>878EA178-9870-4850-916F-4B93B8776D12</gtr:id><gtr:impact>Invited to contribute an article toward the patient group written and delivered British Lung Foundation (Oxfordshire) newsletter on ongoing research in pleural disease and its potential impact

Dissemination of importance of ongoing clinical research</gtr:impact><gtr:outcomeId>8521BD71B80</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9725F444-8D41-4D7B-A59E-9199A7F66499</gtr:id><gtr:impact>Discussion of research results of various outputs in malignant and infective pleural effusion at international American Thoracic Society Conference and American College of Chest Physicians 2010 and 2011.

Invited to be member of postgraduate courses teaching on these subjects in the future</gtr:impact><gtr:outcomeId>eEGQUhmto2Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Thoracic Society Summer Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>93396E85-49BC-4D73-8251-C427CE23958E</gtr:id><gtr:impact>Invited lecture at the national BTS Summer Meeting (educational) to discuss ongoing research projects and future directions for the diagnosis and management of pleural malignancy

Interest from several UK centres in ongoing pleural trials</gtr:impact><gtr:outcomeId>4F9209DCBA0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxfordshire British Lung Foundation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>679874D5-9437-481B-9879-B662A58B01CF</gtr:id><gtr:impact>Invited to a patient group hosted seminar to explain the importance and progress of ongoing pleural trials in malignant pleural disease

Dissemination of importance of practice changing clinical studies and ongoing research interests</gtr:impact><gtr:outcomeId>8E437D75934</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>American College of Chest Physicians, Philadelphia 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>41E6046D-93F8-4250-93C4-B8582B3ADB8B</gtr:id><gtr:impact>Invited lecture on pleural infection, discussing ongoing research and future directions for study

Interest from centres in the USA in ongoing research studies</gtr:impact><gtr:outcomeId>65C9C81411D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Pleural Diseases Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>82CD2664-D00D-4464-9E10-E726F7F725C8</gtr:id><gtr:impact>Invited to lecture on the UK Pleural diseases and Thoracoscopy Course (Dr N Ali, Nottinghamshire) on ongoing pleural research studies

Dissemination of importance of ongoing research, highlighting need for clinical studies adressing basic clinical questions which improve standards of care in pleural disease. Resulted in interest from several UK centres in participation in ongoing trials</gtr:impact><gtr:outcomeId>7993D5A8E8F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Pleural Research Day 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B98A598E-6954-4E54-ADC1-91259C0A4E93</gtr:id><gtr:impact>We hosted a national pleural research day attended by 100 delegates who were respiratory research teams from around the UK and with international speakers. This discussed a number of pleural trials including PILOT and RAMMP, generating significant interest.</gtr:impact><gtr:outcomeId>56e07d6ac25750.41463246</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERS RESPIRE2 fellowship scheme</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>F83E76DD-2FC5-4A95-973C-6C63BDF0D764</gtr:id><gtr:outcomeId>56e0b13a506199.89651847</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>415000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC New Investigator Grant</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A14218F4-4317-42EB-8B0E-2EEAFE2ACBAB</gtr:id><gtr:outcomeId>MST3L9AvGfB0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Walport Clinical Lectureship (4 year post, 50% salary)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E9688423-D88A-4E48-BEE6-9613CE111F40</gtr:id><gtr:outcomeId>7263C799C530</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NCRI and Synermed UK funding (Adjuvant urokinase for the treatment of malignant pleural effusion. The third therapeutic intervention in malignant effusion trial: TIME3-UK)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Cancer Research Institute (NCRI)</gtr:fundingOrg><gtr:id>A40417E2-C51F-4650-B85C-4AEB781DACDC</gtr:id><gtr:outcomeId>92E08AACA330</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BTS pleural disease guidelines committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B55B15C9-7702-49E1-BFF4-BE52B390C987</gtr:id><gtr:impact>Principle fellow for this research was requested to be a member of the BTS Pleural Diseases Guidelines Committee and took a lead in writing the national guideline on Medical Thoracoscopy, due to be published in January 2010.</gtr:impact><gtr:outcomeId>6C6A94DA571</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Accurate measurement of pleural fluid pH</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>BTS Pleural Disease Guidelines</gtr:guidelineTitle><gtr:id>B40F8EBF-BAF5-454A-B14D-A42BAD7053BB</gtr:id><gtr:impact>Accurate measurement of pleural fluid pH for clinical decision making was defined in a study as a result of the research conducted (Pubmed reference 18556632) and is sited in these clinical guidelines as the reference standard for clinical practice in this area</gtr:impact><gtr:outcomeId>ADE97D286C0</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18556632</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Thoracic Society National Guidelines</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>8100C0F4-F688-42C5-8A31-E286E6ECDA02</gtr:id><gtr:impact>The TIME1 trial addresses the questions of whether drain size or analgesic strategy infleunces the pain felt during malignant pleural effusion pleurodesis or affects its efficacy. The avoidance of non-steroidal analgesia and the use of smaller bore chest drains has become widespread throughout the UK, despite no robust evidence on which to base these treatment decisions. Increasing awareness of the rationale behind the TIME1 study has led to these questions remaining open in the latest draft of the National British Thoracic Society Guidelines on Pleural Disease, due to be published in Februaruy 2010.</gtr:impact><gtr:outcomeId>871940A57EA</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In previous studies of pleural effusion, the amount of pleural shadowing on chest radiographs has been categorically &amp;quot;scored&amp;quot; by radiologists, which is a fast but imprecise method of assessing the amount of pleural fluid present. It is recognised that 3d imaging techniques (e.g. thoracic CT) is a more accurate method of assessing pleural fluid volume, but it is impractial and expensive to submit all patients in studies to thoracic CT pre and post intervention for the purposes of a trial alone. We therefore conducted a study assessing the relationship between precise volume of pleural fluid present (as measured by thoracic CT) and a digital measurement strategy using the chest radiograph, in 20 patients undergoing simultaneous thoracic CT and chest radiograph with pleural disease. This demonstrated that a simple and rapidly administered digital measurement strategy using chest radiographs alone is highly correlated to &amp;quot;real&amp;quot; pleural fluid volume as measured by thoracic CT (with an R2 value of 68% in linear regression).</gtr:description><gtr:id>CB145398-7BB8-4A3F-ABCC-9D88E7A91298</gtr:id><gtr:impact>This study is in the process of publication. It will provide an accurate plerual fluid measurement strategy for the TIME1 study, and in addition, provides a simple and effective research tool for future pleural studies allowing accurate quantification of the amount of pleural fluid present using a chest radiograph. This has the potential to alter future trial design, obviating the need for thoracic CT in order to quantify pleural fluid</gtr:impact><gtr:outcomeId>D6ADAFA3A60</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quantification of pleural shadowing on digital measurement of 2 dimensional chest radiographs</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The TIME1 study led to the establishment of several projects in malignant pleural disease which collected biological samples (biopsies and pleural fluid) in conjunction with accurate clinical data. These represent a valuable resource to begin exploring genetic and physiological mechanisms of maligant pleural disease genesis, treatment and models of risk</gtr:description><gtr:id>63B194F3-277C-44B2-87D0-D682958B502F</gtr:id><gtr:impact>Assesssment of potential novel genetic virulence factors in malignant mesothelioma (work in progress). Use of soluble mesothelin to diagnose malignant mesothelioma in pleural fluid (Pubmed reference number : 19299498)</gtr:impact><gtr:outcomeId>7DF900E74FF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pleural disease biobank</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19299498</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Through these two studies (PILOT and RAMMP), we have gained experience and are using the OpenClinica research tool to gather data. This is now occurring highly successfully, and will be used for future funded studies.</gtr:description><gtr:id>82CCF59A-7FBA-4A42-91DF-794800B89C2C</gtr:id><gtr:impact>We will use electronic data capture and design for our future studies.</gtr:impact><gtr:outcomeId>56e07ddb1ac786.46030794</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>OpenClinica experience</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9F72B91D-64D9-4D11-B7E7-88CB5579414B</gtr:id><gtr:title>Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d003cc52d23b4ffd96cbb1cfbe75073"><gtr:id>6d003cc52d23b4ffd96cbb1cfbe75073</gtr:id><gtr:otherNames>Olfert JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>58c3e6a3c58bd2.88294349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C72D4315-6C0E-4C4D-ADE2-28EB4E2861E2</gtr:id><gtr:title>Advanced medical interventions in pleural disease.</gtr:title><gtr:parentPublicationTitle>European respiratory review : an official journal of the European Respiratory Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75087956bb3e646d0f56394959637f4b"><gtr:id>75087956bb3e646d0f56394959637f4b</gtr:id><gtr:otherNames>Bhatnagar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-9180</gtr:issn><gtr:outcomeId>58c3e6a459aec0.02010619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>222DC936-ACCA-4FFB-96C8-9EC690CDE27A</gtr:id><gtr:title>Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>585d55053321f4.36017273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99F84739-338A-45A4-BFE4-EDACF75E6608</gtr:id><gtr:title>Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>1FC37799414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C1D2A25-9CA7-4A0C-89DD-09AC073469AC</gtr:id><gtr:title>Thoracic ultrasound in the diagnosis of malignant pleural effusion.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90053020a043ecdf195fc890cdb7af64"><gtr:id>90053020a043ecdf195fc890cdb7af64</gtr:id><gtr:otherNames>Qureshi NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>8F3A565B225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1791A8B0-9490-4138-8F2A-C95925B4A0EF</gtr:id><gtr:title>Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bc72b072fe77f1af99613e743cf664f"><gtr:id>0bc72b072fe77f1af99613e743cf664f</gtr:id><gtr:otherNames>Idell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5aa6f7466f94c5.64324770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4EAF601-B356-4ADE-B1EF-C26035817A8C</gtr:id><gtr:title>Investigating suspected malignant pleural effusion.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>D643BF09784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23260A34-33F8-49AC-AB78-20D754AF46B7</gtr:id><gtr:title>Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f147270374.97357382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27D93950-E554-4657-A40D-7C9D18E58379</gtr:id><gtr:title>Malignant Pleural Effusion: From Diagnostics to Therapeutics.</gtr:title><gtr:parentPublicationTitle>Clinics in chest medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f75d0b5652c04736625ee9aaf224dc4"><gtr:id>9f75d0b5652c04736625ee9aaf224dc4</gtr:id><gtr:otherNames>Asciak R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0272-5231</gtr:issn><gtr:outcomeId>5aa6f745b3b0c6.62038814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D569CC4-5458-4340-A9ED-D01D1E70DDAB</gtr:id><gtr:title>A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (The AUDIO study).</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>5aa6f744cfdfa3.61014684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FFD9F88-F49A-4B2D-966A-B11C1378100D</gtr:id><gtr:title>Fibrin Turnover and Organization of Pleural Injury: Bench to Bedside.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d1d928c531ab6fa1201b1638448c3c9"><gtr:id>4d1d928c531ab6fa1201b1638448c3c9</gtr:id><gtr:otherNames>Komissarov AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn><gtr:outcomeId>5aa6f746a87c19.36544182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E819DB0-550B-4F57-96B4-559ECA201D44</gtr:id><gtr:title>Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d9fb82cace8cb93e93b155fb2e3e008"><gtr:id>6d9fb82cace8cb93e93b155fb2e3e008</gtr:id><gtr:otherNames>Morel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f1480577f8.66709149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF397BD1-76FB-442E-9F33-C2D78855249B</gtr:id><gtr:title>Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a854b15d222632f64221d2afe25460"><gtr:id>e8a854b15d222632f64221d2afe25460</gtr:id><gtr:otherNames>Mishra EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5aa6f7472c1bf9.87555260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A6D9063-77A7-4F12-9AAC-CE765D2C8247</gtr:id><gtr:title>Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f57b913c43ce2c85c5d3eacf31b9a337"><gtr:id>f57b913c43ce2c85c5d3eacf31b9a337</gtr:id><gtr:otherNames>Davies HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>F5BEE492F2C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>029C09E6-B8E1-4456-8CDC-1FB8BBFF19DE</gtr:id><gtr:title>Pneumocystis jirovecii in pleural infection: a nucleic acid amplification study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddb8d1479f6e741b415fc45aeff3548"><gtr:id>8ddb8d1479f6e741b415fc45aeff3548</gtr:id><gtr:otherNames>Wrightson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f147a76f80.16511538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D45CF124-04E1-4347-8704-3C6F4E1E331B</gtr:id><gtr:title>Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f1477a1939.69947075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C16AD903-E7D5-470B-ABF0-DB4D7E144649</gtr:id><gtr:title>The relationship between chest tube size and clinical outcome in pleural infection.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>5463f146cce617.47172945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04EB5E3B-BA9D-4967-BC59-66E12B897137</gtr:id><gtr:title>Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.</gtr:title><gtr:parentPublicationTitle>Clinical pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bc72b072fe77f1af99613e743cf664f"><gtr:id>0bc72b072fe77f1af99613e743cf664f</gtr:id><gtr:otherNames>Idell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1068-0640</gtr:issn><gtr:outcomeId>5aa6f746e3a7a9.25628276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47F3E6C9-E104-42DD-AF90-11BBA86BB642</gtr:id><gtr:title>Management of parapneumonic effusions and empyema.</gtr:title><gtr:parentPublicationTitle>Seminars in respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1069-3424</gtr:issn><gtr:outcomeId>56e0798fb5ea96.75151045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D6B4B41-E631-4CED-B073-ECE13F99F445</gtr:id><gtr:title>Catheter-tract metastases associated with chronic indwelling pleural catheters.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cbd4704e8b558ff7905c34d182c507c"><gtr:id>9cbd4704e8b558ff7905c34d182c507c</gtr:id><gtr:otherNames>Janes SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>B10690CBD21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32578758-2F51-4CBA-A435-6DB73E0D2322</gtr:id><gtr:title>State of the art thoracic ultrasound: intervention and therapeutics.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5aa6f74773a298.91874799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F0503E4-3024-4B1C-9593-69DD7D88E461</gtr:id><gtr:title>Use of indwelling pleural catheters for chronic pleural infection.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f57b913c43ce2c85c5d3eacf31b9a337"><gtr:id>f57b913c43ce2c85c5d3eacf31b9a337</gtr:id><gtr:otherNames>Davies HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>D96BE124655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B9BE2BE-B1DE-4144-902A-104100458CD5</gtr:id><gtr:title>The role of pleurodesis in respiratory diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe0c38df0c0ce69380b0103c7bcd0d0"><gtr:id>0fe0c38df0c0ce69380b0103c7bcd0d0</gtr:id><gtr:otherNames>Mercer RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1747-6348</gtr:issn><gtr:outcomeId>5aa6f7453a46f2.98294455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58556DD9-9101-4E3E-B63E-D265DE2650A4</gtr:id><gtr:title>Investigation of the patient with pleural effusion.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>9F6F1DF7DA3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AF6245E-FDC9-4C64-8F1A-4199AC8E28CA</gtr:id><gtr:title>Pleural infection: past, present, and future directions.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>56e0798ce41ce4.06710100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1F3A3EC-E5FB-43BC-B7D9-1B5707AFC237</gtr:id><gtr:title>Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>236251651FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F6064E3-BC3B-4C43-A4FA-1F288D59E1C5</gtr:id><gtr:title>Intrapleural use of tissue plasminogen activator and DNase in pleural infection.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5463f14884a5c3.23301263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>584ED18F-5063-4368-BC34-B6145E7EA62E</gtr:id><gtr:title>Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2cc97743e003c4129153149838cf513"><gtr:id>d2cc97743e003c4129153149838cf513</gtr:id><gtr:otherNames>Clive AO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>58c3e6a401adf6.50640734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22C5E254-06E8-4CAA-B02E-E21DEE7EFE8F</gtr:id><gtr:title>New directions in the treatment of infected pleural effusion.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>2DA0A0B860F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42DF89D5-6EA8-4006-AC8B-760C2161BCEB</gtr:id><gtr:title>Pleural procedures and pleuroscopy.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddb8d1479f6e741b415fc45aeff3548"><gtr:id>8ddb8d1479f6e741b415fc45aeff3548</gtr:id><gtr:otherNames>Wrightson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>F422878CAB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF173F52-AF11-4D8A-ADD5-8F3407B4466C</gtr:id><gtr:title>Picking the winners: Outcome prediction in pleural disease.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>5aa6f746302483.30269477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CF5D065-AC52-476B-9B90-13EA6AD54C45</gtr:id><gtr:title>British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd726c06396d645831f2964753a82c6f"><gtr:id>bd726c06396d645831f2964753a82c6f</gtr:id><gtr:otherNames>Woolhouse I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5aa6f74571df71.81081922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F90053F-719F-4DFC-A20D-C6966A7067F3</gtr:id><gtr:title>The inspired sinewave technique: A novel method to measure lung volume and ventilatory heterogeneity.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de00d4e4a4421b2164965225fcb0a925"><gtr:id>de00d4e4a4421b2164965225fcb0a925</gtr:id><gtr:otherNames>Bruce RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn><gtr:outcomeId>5aa6f745eb3f64.83143273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FD850B8-5C2A-4257-8745-98CEAD12E95D</gtr:id><gtr:title>A retrospective validation study of three models to estimate the probability of malignancy in patients with small pulmonary nodules from a tertiary oncology follow-up centre.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fad83689a9dab92dba51d7803d334bb9"><gtr:id>fad83689a9dab92dba51d7803d334bb9</gtr:id><gtr:otherNames>Talwar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>5aa6f747e58175.24926018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C88E5ADD-F100-4B0B-B8CB-8220B7DE3686</gtr:id><gtr:title>Blood culture bottle culture of pleural fluid in pleural infection.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/487cf2b78de92bc1475341b29ea2797a"><gtr:id>487cf2b78de92bc1475341b29ea2797a</gtr:id><gtr:otherNames>Menzies SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f148582a59.85289541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC0B4411-2AAB-4036-9F20-FD63953EB160</gtr:id><gtr:title>Improving standards in flexible bronchoscopy for lung cancer.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c81f69963654764b187609b9af2933a"><gtr:id>2c81f69963654764b187609b9af2933a</gtr:id><gtr:otherNames>Slade MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5463f14751b576.52120595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5AE6D1B-0D9C-418E-997B-E67FBACCAA08</gtr:id><gtr:title>Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.</gtr:title><gtr:parentPublicationTitle>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f57b913c43ce2c85c5d3eacf31b9a337"><gtr:id>f57b913c43ce2c85c5d3eacf31b9a337</gtr:id><gtr:otherNames>Davies HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1010-7940</gtr:issn><gtr:outcomeId>5463f146f2fb33.29791598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D781791C-4F1D-4A3C-97BA-EBFF1457074E</gtr:id><gtr:title>Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/717fb6acab2e2d5beb5c1a5b65903b70"><gtr:id>717fb6acab2e2d5beb5c1a5b65903b70</gtr:id><gtr:otherNames>Arnold DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>58c3e6a39b43d8.31667331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CABC6A1F-13A4-4803-AA9A-2E3708AB7890</gtr:id><gtr:title>Factors influencing the measurement of pleural fluid pH.</gtr:title><gtr:parentPublicationTitle>Current opinion in pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a854b15d222632f64221d2afe25460"><gtr:id>e8a854b15d222632f64221d2afe25460</gtr:id><gtr:otherNames>Mishra EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1070-5287</gtr:issn><gtr:outcomeId>097BC6D9A9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15FFF551-8F4A-4FF7-BD70-7385BE55DF8C</gtr:id><gtr:title>Image-guided pleural biopsy.</gtr:title><gtr:parentPublicationTitle>Current opinion in pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1070-5287</gtr:issn><gtr:outcomeId>3555B81438A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2401CC5B-B841-4939-87EC-385A5FAE939E</gtr:id><gtr:title>Absence of Atypical Pathogens in Pleural Infection.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddb8d1479f6e741b415fc45aeff3548"><gtr:id>8ddb8d1479f6e741b415fc45aeff3548</gtr:id><gtr:otherNames>Wrightson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>56e0798cbdca94.64874326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E30BC9-4309-496E-917D-7692D707B37C</gtr:id><gtr:title>Pleural interventions: management of acute and chronic pneumothorax.</gtr:title><gtr:parentPublicationTitle>Seminars in respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78f61c194983d628228b936087a1577"><gtr:id>a78f61c194983d628228b936087a1577</gtr:id><gtr:otherNames>Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1069-3424</gtr:issn><gtr:outcomeId>0716B86BD13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F9CE4D4-F693-4509-9075-3FC757FB4344</gtr:id><gtr:title>Systematic Review of Microbiology in Pleural Infection</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82e35f00dcc09568994b022170aa4a1c"><gtr:id>82e35f00dcc09568994b022170aa4a1c</gtr:id><gtr:otherNames>Corcoran, John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>qiMPdZMw89C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13BAE4D9-BCC0-4A26-93C1-3AF17BD6AB6D</gtr:id><gtr:title>Chest Drain Size: the Debate Continues.</gtr:title><gtr:parentPublicationTitle>Current pulmonology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5beac8622dd9071ba5403c8696b4b5"><gtr:id>6b5beac8622dd9071ba5403c8696b4b5</gtr:id><gtr:otherNames>Hallifax RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa6f747a968d1.31317369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63548EA3-8EBD-406E-BA00-981DEA2686BA</gtr:id><gtr:title>Advances in pleural disease.</gtr:title><gtr:parentPublicationTitle>European respiratory review : an official journal of the European Respiratory Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-9180</gtr:issn><gtr:outcomeId>58c3e6a48dd4d3.27246417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43C1C7F2-8D12-48E2-A94E-FE5D23FBB7FB</gtr:id><gtr:title>Provision of Day-Case Local Anesthetic Thoracoscopy: A Multicenter Review of Practice.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>58c3e6a36dbcc3.28645629</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600475</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>046212FE-8853-46F0-B1E7-3CBA4770A15F</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.4  Surgery</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>